And to add further, Oncosil has circa $20 million cash in the bank which gives an EV of only $80 million!!!! What a joke. Drug companies with phase 1 data and some only proof of concept, with no Phase 2 or Phase 3 and no regulatory approvals are on much higher valuations.
Market has zero clue about Oncosil. Not even remotely close to a sensible valuation.
Oncosil is about to go into commercialisation and has $20 million cash in the bank, has received regulatory approvals and about to get another half a dozen. And it has a lower valuation compared to last year with all that uncertainty???? What a bloody joke!!!!!!!
OSL Price at posting:
11.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)